MedPath

Home-Based HIT in Obese Individuals

Not Applicable
Completed
Conditions
Obese
Interventions
Behavioral: Training mode
Registration Number
NCT03557736
Lead Sponsor
Liverpool John Moores University
Brief Summary

This study aims to investigate the efficacy of a novel home-based high-intensity interval training (Home-HIT) intervention in obese individuals, with elevated cardiovascular disease (CVD) risk. It was hypothesised that Home-HIT would 1) have high adherence to the prescribed exercise intensity (compliance), 2) improve markers of CVD risk, and 3) lead to favourable skeletal muscle adaptations.

Detailed Description

The applicability of current high intensity interval training (HIT) protocols to the sedentary obese population has been disputed by public health experts. Existing HIT interventions have been successful only under optimal conditions with high levels of supervision and specialised equipment, creating further barriers to exercise in those most in need. We aimed to eliminate many of these barriers by modifying existing HIT protocols to create a new home-based HIT (Home-HIT) intervention tailored to individuals with low fitness and mobility. It was hypothesised that Home-HIT would 1) have high adherence to the prescribed exercise intensity (compliance) and 2) improve markers of cardiovascular disease (CVD) risk. 32 Obese adults with at least 3 additional CVD risk factors (age 36±2 y; BMI 34.3±0.8 kg∙m-2; VO2peak 24.6±1.0 ml∙kg∙min-1), completed one of three 12-week training programmes 3x/week: Home-HIT (n=9); Laboratory-based supervised HIT (Lab-HIT; n=10) or home-based moderate intensity continuous training (Home-MICT; n=13). Adherence and compliance were monitored online in almost "real time" using a heart rate (HR) monitor and mobile app. The Home-HIT group completed 4 progressing to 8 1min intervals interspersed with 1min of rest in an unsupervised place of their choosing. The intervals were composed of simple bodyweight exercises that required no equipment. Changes in VO2peak, insulin sensitivity, body composition, flow-mediated dilation (FMD) and aortic pulse wave velocity (PWV) were assessed. Muscle biopsies were taken to assess changes in capillarisation, mitochondrial density, intramuscular triglyceride (IMTG) content and eNOS and GLUT4 protein expression using quantitative immunofluorescence microscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • obesity (BMI >30 kg/m2)
  • age 18-55
Exclusion Criteria
  • diagnosed CVD and other contraindications to participate in an exercise intervention
  • BMI <30 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lab-HITTraining modeLaboratory-based high-intensity interval training: participants performed supervised cycle exercise under laboratory conditions 3x/week for 12 weeks
Home-HITTraining modeHome-based high-intensity interval training: participants performed 12 weeks of simple body weight exercises in a place of their own choosing 3x/week
Home-MICTTraining modeHome-based moderate-intensity interval training: participants performed 12 weeks of continuous exercise (running, swimming or cycling) in a place of their own choosing 3x/week
Primary Outcome Measures
NameTimeMethod
Adherence and compliance to the exercise training interventionadherance and compliance to the training over the 12 weeks

Session completion rate (adherence) and ability to meet target heart rates (compliance)

change in aerobic fitnesschange in baseline aerobic fitness at 12 weeks

change in maximal aerobic capacity following the training

Secondary Outcome Measures
NameTimeMethod
change in body fat percentagechage in baseline body fat percentage at 12 weeks

change in body fat percentage using DXA with training

change in baseline FMDchange in baseline FMD at 12 weeks

endothelial function measured using flow-mediated dilation (FMD)

change in vascular stiffnesschange in baseline vascular stiffness at 12 weeks

change in vascular stiffness with training

Trial Locations

Locations (1)

Liverpool John Moores University

🇬🇧

Liverpool, Merseyside, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath